Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples